
Erik Rafflenbeul
Latest contributions
Antithrombotic drugs for acute coronary syndromes in women
21 May 2025 – From EuroPCR 2025
Enhance your understanding of antithrombotic drug management in women with acute coronary syndromes (ACS). This session addresses risk stratification balancing ischemic and bleeding risks, evidence-based tailored antithrombotic and revascularisation strategies in high bleeding risk patients, and diagnostic and treatment approaches for MINOCA, with illustrative cases highlighting...

Innovative approaches to rare PCI complications in NSTEMI
16 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions that explore complex PCI scenarios in NSTEMI patients. Participants will learn about rare complications following coronary angioplasty, strategies for identifying the correct culprit lesion, techniques for managing pericardial effusion, and other challenging situations encountered during complex PCI in NSTEMI....

Complications following primary PCI
Consult this session to discover a selection of cases on complications following primary PCI, and learn more about the ping-pong technique, mechanical circulatory support in acute STEMI, an ultrahazardous complication associated with Impella and much more.
